Liu et al. (2020) developed a novel prognostic signature based on ferroptosis and immunity in hepatocellular carcinoma, and the patients in the group with worse prognosis had more suppressors of ferroptosis and higher TP53 mutation frequencies. Here, TP53 is linked to hepatocellular carcinoma.